Massachusetts Financial Services’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-503,246
Closed -$60.9M 886
2023
Q1
$60.9M Buy
503,246
+19,685
+4% +$2.26M 0.02% 415
2022
Q4
$55.5M Hold
483,561
0.02% 421
2022
Q3
$48.9M Sell
483,561
-686
-0.1% -$72.5K 0.02% 442
2022
Q2
$49.1M Buy
484,247
+18,660
+4% +$2.03M 0.02% 454
2022
Q1
$54.2M Buy
465,587
+15
+0% +$1.74K 0.02% 467
2021
Q4
$53.4M Buy
+465,572
New +$53.1M 0.01% 488
2020
Q4
Sell
-316,463
Closed -$35.4M 933
2020
Q3
$35.4M Sell
316,463
-1,982
-0.6% -$222K 0.01% 479
2020
Q2
$33.3M Buy
+318,445
New +$34.1M 0.01% 484

Other funds holding BSX.PRA

Massachusetts Financial Services's BSX.PRA Position: Q2 2023 in Review

Massachusetts Financial Services sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 503,246 shares — an estimated $60.9M sold.

Massachusetts Financial Services first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $60.9M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • Massachusetts Financial Services reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 503,246 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $60.9M.
  • Massachusetts Financial Services first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
  • Massachusetts Financial Services's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $60.9M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Massachusetts Financial Services's 13F filing for Q2 2023, filed 9 Aug 2023.